ZIOPHARM Oncology Inc (ZIOP):企業の財務・戦略的SWOT分析

◆英語タイトル:ZIOPHARM Oncology Inc (ZIOP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH24573FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ziopharm Oncology Inc (Ziopharm), is a provider of next-generation immune therapies. The company offers Controlled IL-12 and t-cell therapy to fight blood cancers and solid tumors. Its Controlled IL-12 platform provides therapy for cold tumors by turning them hot by activating an immune response. The company also provides Sleeping Beauty, a clinically-advanced non-viral cell therapy technology which helps in the manufacturing of genetically modified chimeric antigen receptors (CARs) and T-cell receptors (TCRs) targeting specific tumor-derived antigens. Its products and technologies are used in the treatment of hematologic malignancies, solid tumors and graft-versus-host-disease. The company is headquartered in Boston, Massachusetts, the US.

ZIOPHARM Oncology Inc Key Recent Developments

Apr 07,2021: Ziopharm Oncology to present poster at American Association for Cancer Research Virtual 2021 Annual Meeting
Feb 25,2021: Ziopharm Oncology provides leadership and corporate updates; reports fourth quarter and full year 2020 financial results
Feb 17,2021: Ziopharm Oncology appoints Timothy Cunningham as interim Chief Financial Officer
Feb 16,2021: Ziopharm Oncology to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast on February 25, 2021
Feb 05,2021: Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors

This comprehensive SWOT profile of ZIOPHARM Oncology Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ZIOPHARM Oncology Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

ZIOPHARM Oncology Inc – Key Information
ZIOPHARM Oncology Inc – Overview
ZIOPHARM Oncology Inc – Key Employees
ZIOPHARM Oncology Inc – Key Employee Biographies
ZIOPHARM Oncology Inc – Key Operational Heads
ZIOPHARM Oncology Inc – Major Products and Services
ZIOPHARM Oncology Inc – History
ZIOPHARM Oncology Inc – Company Statement
ZIOPHARM Oncology Inc – Locations And Subsidiaries
ZIOPHARM Oncology Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

ZIOPHARM Oncology Inc – Business Description
ZIOPHARM Oncology Inc – Corporate Strategy
ZIOPHARM Oncology Inc – SWOT Analysis
SWOT Analysis – Overview
ZIOPHARM Oncology Inc – Strengths
ZIOPHARM Oncology Inc – Weaknesses
ZIOPHARM Oncology Inc – Opportunities
ZIOPHARM Oncology Inc – Threats
ZIOPHARM Oncology Inc – Key Competitors

Section 3 – Company Financial Performance Charts

ZIOPHARM Oncology Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

ZIOPHARM Oncology Inc, Key Information
ZIOPHARM Oncology Inc, Key Ratios
ZIOPHARM Oncology Inc, Share Data
ZIOPHARM Oncology Inc, Major Products and Services
ZIOPHARM Oncology Inc, History
ZIOPHARM Oncology Inc, Key Employees
ZIOPHARM Oncology Inc, Key Employee Biographies
ZIOPHARM Oncology Inc, Key Operational Heads
ZIOPHARM Oncology Inc, Other Locations
ZIOPHARM Oncology Inc, Subsidiaries
ZIOPHARM Oncology Inc, Key Competitors
ZIOPHARM Oncology Inc, SWOT Analysis
ZIOPHARM Oncology Inc, Ratios based on current share price
ZIOPHARM Oncology Inc, Annual Ratios
ZIOPHARM Oncology Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ZIOPHARM Oncology Inc (ZIOP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Greif, Inc.:企業の戦略・SWOT・財務分析
    Greif, Inc. - Strategy, SWOT and Corporate Finance Report Summary Greif, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • LifeAssays AB (LIFE B):医療機器:M&Aディール及び事業提携情報
    Summary LifeAssays AB (LifeAssays) is a medical device company that develops, manufactures and markets in-vitro diagnostic and veterinary care products. The company offers point-of-care diagnostic testing systems. It provides product portfolio such as lifeassays human system and lifeassays veterinar …
  • China Southern Airlines Company Limited:戦略・SWOT・企業財務分析
    China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Ion Beam Applications SA (IBAB)-医療機器分野:企業M&A・提携分析
    Summary Ion Beam Applications SA (IBA) is a medical technology company that develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses i …
  • New Zealand Energy Corp (NZ):企業の財務・戦略的SWOT分析
    Summary New Zealand Energy Corp (New Zealand Energy), formerly East Coast Energy Ventures Ltd is an oil and gas company. The company carries out the business of production, development and exploration of conventional and unconventional oil and natural gas prospects in New Zealand. It acquires strate …
  • International Drug Development Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical serv …
  • NGK Spark Plug Co Ltd:戦略・SWOT・企業財務分析
    NGK Spark Plug Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NGK Spark Plug Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Melrose Industries PLC (MRO):企業の財務・戦略的SWOT分析
    Summary Melrose Industries PLC (Melrose) is an investment company that improve and sell industrial and manufacturing businesses. The company offers products such as air management, security, home automation and ergonomic and electricity generating equipment. Its business portfolio comprises of Norte …
  • United Technologies Corporation:企業の戦略・SWOT・財務情報
    United Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary United Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Anixter International Inc.:企業の戦略・SWOT・財務情報
    Anixter International Inc. - Strategy, SWOT and Corporate Finance Report Summary Anixter International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Accelerate Diagnostics Inc (AXDX):企業の財務・戦略的SWOT分析
    Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Petroliam Nasional Bhd:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroliam Nasional Bhd (Petronas) is an integrated oil and gas company that explores, develops and produces of oil and natural gas in Malaysia and overseas. It also carries out downstream operations such as processing and liquefaction of natural gas; refining and marketing of petroleum produ …
  • CONSOL Energy Inc.:企業の戦略・SWOT・財務情報
    CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Natera Inc (NTRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Newmont Mining Corp:企業の戦略・SWOT・財務情報
    Newmont Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Newmont Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • High-Tech Grunderfonds Management GmbH:企業のM&A・事業提携・投資動向
    High-Tech Grunderfonds Management GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's High-Tech Grunderfonds Management GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Banca Transilvania S.A.:企業の戦略・SWOT・財務情報
    Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Amtek Auto Limited:企業のM&A・事業提携・投資動向
    Amtek Auto Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amtek Auto Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Tampa Electric Co:企業の戦略的SWOT分析
    Tampa Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Ampio Pharmaceuticals Inc (AMPE):製薬・医療:M&Aディール及び事業提携情報
    Summary Ampio Pharmaceuticals Inc (Ampio), formerly Chay Enterprises Inc is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆